Analyst Insight: To address changing patient and market needs, pharmaceutical companies are expanding their product portfolios to include specialized and even individualized drugs. Precise, real-time control is indispensable to avoiding quality issues during the production or shipment of these smaller-batch items. To support this growing trend, systems of the extended supply chain need to be integrated to provide synchronization and process visibility.
Healthcare supply chains tend to be high-margin, regulated businesses with strict quality requirements, such as the need for cold-chain storage and transportation. Yet they’re often ripe for improvements across the board.
In a complex modern-day global supply chain, how can companies assess which suppliers present the highest level of risk to business continuity? And how can they begin to implement effective risk-management programs based on end-to-end visibility?
Instead of the two to three weeks taken by current treatments from American and European drug makers, a Shanghai-based company is churning out cancer-killing immune cells overnight.
The latest supply-chain news, analysis, trends and tools for executives in the pharmaceutical and biotech industries. Learn how pharmaceutical and biotech companies and their suppliers around the world are managing the flow of products across all channels of the enterprise. Experts sound off on forecasting and demand planning, supply-chain visibility, logistics outsourcing, inventory optimization, transportation management, warehouse management, supply-chain security, corporate social responsibility and more.
Subscribe to our Daily Newsletter!
Timely, incisive articles delivered directly to your inbox.